Revisiting NICE guidelines for initiation of intravitreal anti-VEGF therapy for centre-involving diabetic macular oedema: a survey of current interpretation in the United Kingdom

Eye (Lond). 2022 Sep;36(9):1832-1834. doi: 10.1038/s41433-022-01935-5. Epub 2022 Jan 25.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / drug therapy
  • Humans
  • Intravitreal Injections
  • Macular Edema* / drug therapy
  • Ranibizumab / therapeutic use
  • Tomography, Optical Coherence
  • United Kingdom

Substances

  • Angiogenesis Inhibitors
  • Ranibizumab